About Onco
Aims
Onco (ISSN 2673-7523) is a peer-reviewed Open Access journal on oncotargets and cancer therapies, published online by MDPI. It publishes article types including Research Papers, Reviews, Editorials, Communications, etc. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. The full experimental details must be provided so that the results can be reproduced.
Scope
Onco functions as a scientific forum to integrate novel preclinical, translational and clinical cancer research with a primary focus on oncotargets and cancer therapies. The journal invites submissions of original research, reviews, editorials and commentaries covering a broad range of scientific domains, including (but not limited to):
- Cancer cell signaling;
- Cancer genetics and molecular targets;
- Cancer epigenetics and heterogeneity;
- Carcinogenesis and cancer evolution;
- Microbiome and cancer;
- Cancer metabolomics;
- Cancer biomarkers;
- Cancer dormancy;
- Novel targeted and immune cancer therapies;
- Randomized clinical trials;
- Oncotargets;
- Cancer therapies;
- Clinical reports proposing novel therapeutic regimens.
Short reports can be considered, provided that they present a clear relationship with one or more of the above topics.
Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. The experimental details must be provided so that the results can be reproduced.
Onco’s Editorial Board, consisting of international experts from leading institutions, oncology centers and universities in cancer research, aims to promote the evolving field of oncology.
MDPI Publication Ethics Statement
MDPI is a member of the Committee on Publication Ethics (COPE).
MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add
high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate
authorship credit, and the like, do arise. MDPI takes such publishing ethics issues very seriously and our editors are trained to proceed in
such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications.
Book Reviews
Authors and publishers are encouraged to send review copies of their recent related books to the following address. Received books will be listed as Books Received within the journal's News & Announcements section.
MDPI
Grosspeteranlage 5
CH-4052 Basel
Switzerland
Copyright / Open Access
Articles published in Onco will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text:
Reprints may be ordered. Please contact for more information on how to order reprints. Announcements regarding academic activities such as conferences are published for free in the News & Announcements section of the journal. Advertisement can be either published or placed on the pertinent website. Contact e-mail address is . For further MDPI contacts, see here.Reprints
Announcement and Advertisement
Editorial Office
Contact us
